Covered recipient · General Payments record
NICHOLA NELSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$4,477.71
- Reported across 177 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,292.79 | 53 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $192.30 | 5 |
| Janssen Biotech, Inc. | $170.32 | 8 |
| Acerta Pharma LLC | $110.59 | 4 |
| Merck Sharp & Dohme Corporation | $84.58 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $78.91 | 3 |
| ABBVIE INC. | $62.22 | 2 |
| Regeneron Healthcare Solutions, Inc. | $58.02 | 2 |
| Daiichi Sankyo Inc. | $57.32 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $53.92 | 2 |
| PFIZER INC. | $50.26 | 2 |
| Lilly USA, LLC | $48.23 | 2 |
| SOBI, INC | $45.90 | 2 |
| Mirati Therapeutics, Inc. | $35.72 | 1 |
| GlaxoSmithKline, LLC. | $34.10 | 1 |
| PharmaEssentia USA Corporation | $31.17 | 1 |
| Tempus AI, Inc | $27.74 | 1 |
| Adaptive Biotechnologies Corporation | $24.21 | 1 |
| Genentech USA, Inc. | $22.95 | 1 |
| GENZYME CORPORATION | $21.84 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.34 | 1 |
| Kyowa Kirin, Inc. | $20.72 | 1 |
| SpringWorks Therapeutics, Inc. | $20.52 | 1 |
| Blueprint Medicines Corporation | $19.69 | 1 |
| Immunocore Limited | $19.02 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.80 | 1 |
| SECURA BIO, INC. | $17.73 | 1 |
| Fennec Pharmaceuticals, Inc. | $16.36 | 1 |
| ADC Therapeutics America, Inc. | $14.57 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.